ADRIATIC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
ADRIATIC
Jun 24, 2024, 17:19 |
Blog
David R. Spigel commented on the major lung cancer research updates for Patient Power
Sarah Cannon Research Institute shared on LinkedIn: .…
Jun 23, 2024, 09:25 |
Insight
David R. Spigel comments on CROWN, LAURA, and ADRIATIC studies
Sarah Cannon Docs shared on X: ""It's just kind of blown everyone away that the…
Jun 15, 2024, 15:32 |
Blog
Yüksel Ürün: As a GU oncologist my non-GU key highlights from ASCO24
Yüksel Ürün shared on X/Twitter: "As a GU oncologist my non-GU key highlights from ASCO24. 1.…
Jun 5, 2024, 11:51 |
Blog
Patrick Forde: Initial thoughts I will bring back to clinic from ASCO24
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies at Sidney Kimmel Comprehensive Cancer Center,…
Jun 4, 2024, 03:08 |
Societies
ASCO24 Day 3 Highlights by The Oncology Brothers
The Oncology Brothers shared on X: "1. DB06 TDxD HR+ metastatic breast cancer (mBC) 2.…
May 31, 2024, 07:45 |
Insight
Aakash Desai: ASCO24 set to showcase some SCLC research, hopefully pushing boundaries in this field
Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared on LinkedIn: “T-2 ASCO24…
May 28, 2024, 08:21 |
Blog
Antonio Passaro's top 10 selection with explanation, among the lung cancer abstracts from ASCO24
Antonio Passaro, shared a post on X: ''ASCO24 is ready to start soon! Here, my top…
Apr 28, 2024, 11:04 |
Blog
Ana I. Velázquez Mañana: ASCO24 abstract titles are out! Exciting Plenary Session, specially for LCSM community
Ana I. Velázquez Mañana shared on X/Twitter: “ASCO24 abstract titles are out! Exciting Plenary Session, specially…
All:
8
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube